Well, that's two pretty solid product launches and one that's still a bit hand-wavy (Endo).
Expenditure has averaged $2m/q for several years now, $3m is a bit high but comparable with Q3 and Q4 2022, not long after the Sonic deal when they were supposed to be heading to commercialisation then.
(In retrospect, a red flag with the Sonic deal was that, in return for only paying a royalty, there was no up front cash from them or a commitment to cover all the commercialisation costs.)
So 3m/q is a bit high but not unprecedented.
But it does mean that they've really only got until the end of 2025 to prove themselves.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
PIQ
proteomics international laboratories ltd
Add to My Watchlist
1.39%
!
35.5¢

Well, that's two pretty solid product launches and one that's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $58.10M |
Open | High | Low | Value | Volume |
35.0¢ | 35.5¢ | 34.0¢ | $52.70K | 153.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6548 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 2035 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6548 | 0.355 |
2 | 17384 | 0.345 |
2 | 9172 | 0.340 |
2 | 3492 | 0.335 |
4 | 18540 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 2035 | 1 |
0.365 | 9405 | 1 |
0.370 | 100000 | 1 |
0.380 | 50000 | 1 |
0.395 | 39195 | 2 |
Last trade - 15.25pm 04/08/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online